Loading clinical trials...
Loading clinical trials...
A Randomized, Single-blind, Placebo-controlled Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA BN® RSV Vaccine in Healthy Adult Subjects
Conditions
Interventions
MVA BN RSV
Placebo
Locations
1
United States
Johnson County Clin-Trials (JCCT)
Lenexa, Kansas, United States
Start Date
August 1, 2015
Primary Completion Date
December 1, 2015
Completion Date
May 1, 2016
Last Updated
August 10, 2016
NCT07220109
NCT07092865
NCT07239583
NCT06534892
NCT04919109
NCT07235397
Lead Sponsor
Bavarian Nordic
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions